With its high electrical conductivity and optical transparency, indium tin oxide is one of the most widely used materials for touchscreens, plasma displays, and flexible electronics. But its rapidly escalating price has forced the electronics industry to search for other alternatives.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that it has entered into an amendment of its existing credit facility from Hercules Technology III, L.P., an affiliate of Hercules Technology Growth Capital. Under the amendment, the company borrowed an additional $15 million in growth capital, less the repayment of the outstanding balance on BIND’s existing term loan facility of approximately $3 million.
Michael Liehr, Executive Vice President of Innovation and Technology at the State University of New York (SUNY) Polytechnic Institute, will give a talk at 10 a.m. Friday, Jan. 30, in Room 1065 of Kemper Hall on the UC Davis campus. The event is hosted by S.J. Ben Yoo, a professor in the UC Davis Department of Electrical and Computer Engineering. The talk is presented as part of the College of Engineering’s Distinguished Lecture Series.
Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for ABRAXANE® (paclitaxel formulated as albumin-bound nanoparticles, or nab-paclitaxel) in combination with carboplatin for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
NanoViricides, Inc. (the "Company"), a nanomedicine company developing anti-viral drugs, reported a good safety profile of an optimized FluCide® drug candidate in a GLP-like toxicology study in rats. These results are extremely important since they indicate that FluCide continues to look very promising as one of the most advanced candidates in the Company's drug development pipeline.
STOE's WinXPOW software now includes a new module for easy evaluation of powder diffraction measurements - SYSTEVAL.
Scientists from the University of Twente have developed spherical gold particles which are capable of drilling a nano-diameter tunnel in a ceramic material upon heating.
NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reported that it has shipped several anti-Ebola nanoviricide® drug candidates to a hi-security bio-containment facility in the US that is capable of performing evaluation of these drug candidates in the required biological safety level 4 (BSL-4) environment.
TechNavio, a tech-focused research firm, has published a new report on the Global Carbon Nanotubes (CNTs) Market, which is expected to grow at a CAGR of 14.84 percent from 2014-2019.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced the publication of an article in the Journal of the American Medical Association (JAMA) co-authored by Robert S. Langer, Sc.D, David H. Koch Institute Professor, Massachusetts Institute of Technology, co-founder and member of the Board of Directors of BIND and one of seven individuals to have received both the United States National Medal of Science and the United States National Medal of Technology and Innovation.
James Baker, Business Director for Graphene@Manchester writes about the forthcoming Graphene Engineering Innovation Centre following a recent visit to leading UK materials manufacturing facilities.
NanoMarkets has announced the release of a new report titled, "Smart Coatings Markets 2015-2022," a report that continues the firm's coverage of the smart coatings market, dating back to 2010.
Mobile phones and smart phones still haven‘t been adapted to the carrying habits of their users. That much is clear to anyone who has tried sitting down with a mobile phone in their back pocket: the displays of the innumerable phones and pods are rigid and do not yield to the anatomical forms adopted by the people carrying them.
Natural materials have extraordinary mechanical properties, which are based on sophisticated arrangements and combinations of multiple building blocks. One key aspect of today’s materials research therefore is to develop bio-inspired materials reaching to the properties of natural materials – or even exceeding those in certain functionalities.
Scientists from ICFO, MIT, CNRS, CNISM and Graphenea have conducted a study on active electrical control of energy flow from erbium ions into plasmons and photons.
By Alexander Chilton
22 Jan 2015